Measuring reconceptualization and reprioritization during France's first COVID-19-related lockdown in women with and without a history of cancer: an adaptation of the SeiQol-DW and PGI

Qual Life Res. 2024 May;33(5):1423-1431. doi: 10.1007/s11136-024-03626-y. Epub 2024 Mar 19.

Abstract

Purpose: This study aimed to provide a better understanding of the patient-perceived effects of France's first COVID-19-related lockdown on the quality of life (QoL) of women affected by cancer, and to test an ad hoc measurement scale for evaluating quasi-individualized QoL. QoL was measured for both during (i.e., current) and before (i.e., retrospectively) the lockdown. Respondents were women registered on the research platform Seintinelles.

Methods: A tool for measuring quasi-individualized QoL was adapted from the SeiQol-DW and PGI. It was distributed as part of a larger online self-questionnaire to a sample of 1303 women with a history of cancer (i.e., former or current) and with no such history.

Results: Current and retrospective QoL scores were not significantly different between the two respondent groups. An analysis of reconceptualization and reprioritization revealed a cancer-specific effect: women with a history of cancer reconceptualized more, while women with no such history reprioritized more.

Conclusion: Our novel ad hoc quasi-qualitative tool made it possible to assess the QoL of women with a history of cancer, a particularly vulnerable population in the context of the COVID-19 pandemic. Furthermore, it highlighted a difference in reconceptualization and reprioritization between this population and women with no such history.

Keywords: Cancer; Lockdown; Quality of life; Reconceptualization; Reprioritization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • COVID-19* / epidemiology
  • COVID-19* / psychology
  • Female
  • France / epidemiology
  • Humans
  • Middle Aged
  • Neoplasms* / psychology
  • Pandemics
  • Quality of Life*
  • Quarantine / psychology
  • Retrospective Studies
  • SARS-CoV-2*
  • Surveys and Questionnaires